Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.9900
0.00 (0.00%)
Jun 5, 2025, 10:25 AM - Market open
Opus Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 13.65 | 10.99 | 19.05 | 39.85 | 0.59 | - | Upgrade
|
| Revenue Growth (YoY) | -28.19% | -42.30% | -52.20% | 6665.70% | - | - | Upgrade
|
| Cost of Revenue | 26.85 | 26.85 | 17.65 | 14.36 | 15.17 | 6.65 | Upgrade
|
| Gross Profit | -13.2 | -15.86 | 1.4 | 25.5 | -14.58 | -6.65 | Upgrade
|
| Selling, General & Admin | 19.89 | 18.22 | 11.96 | 7.27 | 8.12 | 2.82 | Upgrade
|
| Research & Development | 3.2 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 23.1 | 18.22 | 11.96 | 7.27 | 8.12 | 2.82 | Upgrade
|
| Operating Income | -36.3 | -34.07 | -10.56 | 18.23 | -22.71 | -9.47 | Upgrade
|
| Interest Expense | - | - | -1.33 | -0.01 | -0 | -6.85 | Upgrade
|
| Interest & Investment Income | 2 | 2 | 1.8 | 0.16 | 0 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 3.69 | 2.56 | 0.15 | - | -33.83 | -1.48 | Upgrade
|
| EBT Excluding Unusual Items | -30.61 | -29.52 | -9.94 | 18.37 | -56.53 | -17.79 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.01 | -0.01 | -0.03 | -0.17 | -0.07 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.09 | 3.67 | Upgrade
|
| Pretax Income | -58.62 | -57.53 | -9.97 | 18.2 | -56.69 | -24.62 | Upgrade
|
| Income Tax Expense | - | - | 0.01 | 0.32 | - | - | Upgrade
|
| Net Income | -58.62 | -57.53 | -9.99 | 17.89 | -56.69 | -24.62 | Upgrade
|
| Net Income to Common | -58.62 | -57.53 | -9.99 | 17.89 | -56.69 | -24.62 | Upgrade
|
| Shares Outstanding (Basic) | 29 | 27 | 22 | 20 | 15 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 27 | 22 | 21 | 15 | 5 | Upgrade
|
| Shares Change (YoY) | 29.23% | 23.74% | 4.82% | 38.68% | 218.65% | 63.84% | Upgrade
|
| EPS (Basic) | -2.02 | -2.15 | -0.46 | 0.90 | -3.82 | -5.28 | Upgrade
|
| EPS (Diluted) | -2.02 | -2.15 | -0.46 | 0.87 | -3.82 | -5.28 | Upgrade
|
| Free Cash Flow | - | -25.58 | -1.11 | 14.31 | -19.47 | -8.27 | Upgrade
|
| Free Cash Flow Per Share | - | -0.96 | -0.05 | 0.69 | -1.31 | -1.77 | Upgrade
|
| Gross Margin | -96.70% | -144.28% | 7.33% | 63.98% | - | - | Upgrade
|
| Operating Margin | -265.88% | -309.99% | -55.45% | 45.74% | -3854.84% | - | Upgrade
|
| Profit Margin | -429.42% | -523.40% | -52.42% | 44.89% | -9625.30% | - | Upgrade
|
| Free Cash Flow Margin | - | -232.68% | -5.84% | 35.92% | -3305.60% | - | Upgrade
|
| EBITDA | -36.28 | -34.06 | -10.56 | 18.23 | -22.7 | -9.46 | Upgrade
|
| EBITDA Margin | -265.80% | - | -55.42% | 45.75% | - | - | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0 | 0 | 0.01 | Upgrade
|
| EBIT | -36.3 | -34.07 | -10.56 | 18.23 | -22.71 | -9.47 | Upgrade
|
| EBIT Margin | -265.88% | - | -55.45% | 45.74% | - | - | Upgrade
|
| Effective Tax Rate | - | - | - | 1.73% | - | - | Upgrade
|
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.